Clinical Chemistry Conference

  Dr Roffey brings over 20 years of drug discovery experience gained in the pharmaceutical and biotechnology sectors, where he contributed to the development of multiple candidate drugs and late-stage clinical assets. He has extensive experience in a variety of therapeutic areas, including central nervous system, oncology and metabolic disorders across a range of therapeutic modalities. He joins from Nanna Therapeutics, where he was Head of Drug Discovery and led a portfolio of mitochondrial targeted programs to treat rare diseases.  Prior to that, he was Director of Chemistry at Azeria Therapeutics, a company he helped spin-out from the University of Cambridge.   Previously, at Cancer Research Technology, he was a Senior Group Leader and at Spirogen, he led and established the antibody drug conjugate programme, which led to the clinical development of vadastuximab talirine and rovalpituzumab tesirine.  He started his Medicinal chemistry career at Vernalis, as a...

  Frontiers in Natural Product Chemistry  is a book series devoted to important advances in natural product chemistry. The series features volumes that cover all aspects of research in the chemistry and biochemistry of naturally occurring compounds, including research on natural substances derived from plants, microbes and animals. Reviews of structure elucidation, biological activity, and organic and experimental synthesis of natural products as well as developments of new methods are also included in the series. Volume 10 of the series brings together 5 reviews on a variety of bioactive compounds. An overview of cistus species growing in Sardinia - A source of bioactive compounds. Roles of natural acids in fruits during fruit development and under environmental stress. Progress in the research of naturally occurring flavonoids. A look through Plant metabolites for protecting human cells against radiation-associated damage - An integrative review. Chemical perspective and dra...

  The initiative is aimed at recognizing the contribution of doctors to India’s healthcare industry Tata 1mg, a digital health company, has announced complimentary health check-ups for more than 1,000 doctors across India. The company will also felicitate 500 doctors this month as part of a nationwide campaign to recognize  and appreciate the contribution of doctors to India’s healthcare industry. The participant doctors would be checked on more than 70 health parameters, including liver function test, kidney function test, thyroid profile, glucose, lipid profile, vitamin D, and vitamin B12. “Doctors are vulnerable to the same acute and chronic conditions as the patients they treat. Yet, in the pursuit of their profession, they often neglect their own health and do not extend the same empathy and care to themselves as they do to their patients. This is a matter of great concern as doctors are national assets, as seen by their relentless service during the pandemic,” said Prash...

According to Report Ocean report Global Clinical Chemistry Analyzer Market: By Product Type (Analyzer, Reagent), By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function, Others), By Region, By Country (2019 Edition): Opportunities and Forecast (2013-2023) – By Region (North America, Europe, APAC, ROW), By Country (U.S, Canada, U.K, Germany, China, India, Japan, Brazil),  Global Clinical Chemistry Analyzer Market is projected to display a positive growth represented by a CAGR of 10.78% during 2018 2023. A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Clinical Chemistry Analyzer Market. The Global Clinical Chemistry Analyzer Market has been analyzed By Test Type (Basic Metabolic Panel, Lipid Profile, Liver Profile, Electrolytes, Renal Profile, Thyroid Function & Others)...